[go: up one dir, main page]

CN1957288B - Method for producing protein adsorption-preventing ocular lens material - Google Patents

Method for producing protein adsorption-preventing ocular lens material Download PDF

Info

Publication number
CN1957288B
CN1957288B CN2005800168463A CN200580016846A CN1957288B CN 1957288 B CN1957288 B CN 1957288B CN 2005800168463 A CN2005800168463 A CN 2005800168463A CN 200580016846 A CN200580016846 A CN 200580016846A CN 1957288 B CN1957288 B CN 1957288B
Authority
CN
China
Prior art keywords
contact lens
compound
group
phosphorylcholine
terminal amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800168463A
Other languages
Chinese (zh)
Other versions
CN1957288A (en
Inventor
石原一彦
隅田如光
宫泽和之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2005136846A external-priority patent/JP3738027B2/en
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of CN1957288A publication Critical patent/CN1957288A/en
Application granted granted Critical
Publication of CN1957288B publication Critical patent/CN1957288B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Eyeglasses (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Disclosed is a method for producing an ocular lens material which comprises a step for reacting and covalently bonding a compound having a phosphorylcholine group represented by the formula (1) below with the surface of an ocular lens material. This method for producing an ocular lens material is characterized in that a compound having a terminal amino group is introduced into the surface of the ocular lens material and then a compound represented by the formula (2) or (3) below is introduced thereinto through the compound having the terminal amino group. The object of the present invention is to provide a method of manufacturing a contact lens that prevents protein adsorption. In the formula (2), n is a natural number of 1-18.

Description

防止蛋白质吸附的眼镜材料的制造方法Method for producing eyeglass material that prevents protein adsorption

技术领域technical field

本发明涉及隐形眼镜等眼镜材料的制造方法和防止蛋白质吸附的方法。更具体的说,涉及通过含磷酸胆碱基的化合物的后处理,对眼镜材料的表面(特别是隐形眼镜)进行处理,防止蛋白质污垢的方法。The present invention relates to a method for producing lens materials such as contact lenses and a method for preventing protein adsorption. More specifically, it relates to a method for preventing protein fouling by treating the surface of lens materials (especially contact lenses) by post-treatment with phosphorylcholine group-containing compounds.

背景技术Background technique

将含磷酸胆碱基的单体聚合,用作隐形眼镜材料,这是公知的方法(专利文献1-3)。例如,专利文献1中公开了含有含磷酸胆碱基的(甲基)丙烯酸酯作为构成单元的含水性软性隐形眼镜,并记载:其含水率、透氧性、拉伸强度优异,蛋白质吸附量少,可以抑制污垢的附着。It is a known method to polymerize phosphorylcholine group-containing monomers and use them as contact lens materials (Patent Documents 1-3). For example, Patent Document 1 discloses a water-containing soft contact lens containing a phosphorylcholine group-containing (meth)acrylate as a constituent unit, and describes that it is excellent in water content, oxygen permeability, and tensile strength, and has excellent protein adsorption properties. A small amount can suppress the adhesion of dirt.

关于隐形眼镜的后处理方法,专利文献4中记载:使含磷酸胆碱基的单体在隐形眼镜表面聚合,制造具有亲水性表面、蛋白质吸附少的隐形眼镜。Regarding post-treatment methods for contact lenses, Patent Document 4 describes: polymerizing phosphorylcholine group-containing monomers on the surface of contact lenses to produce contact lenses with a hydrophilic surface and less protein adsorption.

专利文献5中公开了:将低分子的磷酸胆碱化合物与隐形眼镜表面化学键合,以降低蛋白吸附的方法。Patent Document 5 discloses a method of chemically bonding a low-molecular phosphorylcholine compound to the surface of a contact lens to reduce protein adsorption.

即,专利文献5的实施例5中记载了将甘油磷酸胆碱进行1,1’-羰基二咪唑处理,向含有甲基丙烯酸羟基乙酯共聚物的隐形眼镜表面导入磷酸胆碱基的方法。但是,对上述反应进行验证试验时,结果并未能获得所希望的经磷酸胆碱处理的隐形眼镜。That is, Example 5 of Patent Document 5 describes a method in which glycerophosphorylcholine is treated with 1,1'-carbonyldiimidazole to introduce phosphorylcholine groups into the surface of a contact lens containing a hydroxyethyl methacrylate copolymer. However, when a verification test was carried out on the above reaction, the desired phosphorylcholine-treated contact lens could not be obtained.

专利文献5的反应式6中记载了磷酸胆碱羧基化合物转变为活性酯的化学结构式。关于其合成方法、实施例均未有记载,因此无法进行验证试验,但是根据通常的有机化学常识,在合成具有所记载的结构的磷酸胆碱羧基化合物时,其方法极其复杂,收率低,因此可容易地类推其缺乏实用性。Reaction Formula 6 of Patent Document 5 describes the chemical structural formula in which the phosphorylcholine carboxyl compound is converted into an active ester. All there is no record about its synthetic method, embodiment, therefore can't carry out verification test, but according to common organic chemistry general knowledge, when synthesizing the phosphorylcholine carboxyl compound with the recorded structure, its method is extremely complicated, and yield is low, Its lack of utility can thus be easily deduced by analogy.

如上所述,专利文献5中所记载的处理方法并没有记载对隐形眼镜进行处理的含羧基含磷酸胆碱基的化合物的合成方法,无法立即实施所记载的方法。并且,向隐形眼镜表面导入磷酸胆碱基的反应也无法在这些专利文献所记载的条件下充分进行,其导入量低,因此并不能显示优异的防止蛋白质吸附的效果。As described above, the treatment method described in Patent Document 5 does not describe a method for synthesizing a carboxyl group-containing phosphorylcholine group-containing compound for treating contact lenses, and the described method cannot be immediately implemented. In addition, the reaction of introducing phosphorylcholine groups to the surface of contact lenses cannot sufficiently proceed under the conditions described in these patent documents, and the introduction amount is low, so the excellent effect of preventing protein adsorption cannot be exhibited.

另一方面,隐形眼镜的污垢是泪液中所含蛋白质或脂质吸附,成为污垢,该污垢有引发变态反应或感染等眼部疾病的危险(非专利文献1)。特别是以甲基丙烯酸2-羟基乙酯的聚合物为主要成分的含水软性隐形眼镜或其中少量共聚离子性单体的甲基丙烯酸而得到的高含水软性眼镜、或者作为亲水性单体,以N-乙烯基吡咯烷酮或N,N-二甲基丙烯酰胺的聚合物为主要成分的软性隐形眼镜中,蛋白质的污垢是致命的问题。On the other hand, stains on contact lenses are caused by the adsorption of proteins or lipids contained in tears to become stains, which may cause eye diseases such as allergies and infections (Non-Patent Document 1). In particular, the water-containing soft contact lens mainly composed of 2-hydroxyethyl methacrylate polymer or the highly water-containing soft contact lens obtained by copolymerizing a small amount of methacrylic acid as an ionic monomer, or as a hydrophilic single contact lens In soft contact lenses mainly composed of polymers of N-vinylpyrrolidone or N,N-dimethylacrylamide, protein fouling is a fatal problem.

专利文献1:日本特开平10-177152号公报Patent Document 1: Japanese Patent Application Laid-Open No. 10-177152

专利文献2:日本特开2000-111847号公报Patent Document 2: Japanese Patent Laid-Open No. 2000-111847

专利文献3:日本特开2000-169526号公报Patent Document 3: Japanese Patent Laid-Open No. 2000-169526

专利文献4:日本特开2001-337298号公报Patent Document 4: Japanese Patent Laid-Open No. 2001-337298

专利文献5:日本特表平5-505121号公报Patent Document 5: Japanese Patent Application Publication No. 5-505121

非专利文献1:“软性隐形眼镜的污垢及其分析”、マテリアルステ一ジ、Vol.4、No.1、2004Non-Patent Document 1: "Staining of Soft Contact Lenses and Its Analysis", Material Stealth, Vol.4, No.1, 2004

发明内容Contents of the invention

本发明提供一种隐形眼镜,通过对隐形眼镜进行后处理,经由具有末端氨基的化合物,使磷酸胆碱基与隐形眼镜表面共价键合,抑制蛋白质吸附隐形眼镜,防止蛋白质污垢。The invention provides a contact lens. After post-processing the contact lens, the phosphorylcholine group is covalently bonded to the surface of the contact lens through a compound having an amino terminal group, thereby inhibiting protein adsorption to the contact lens and preventing protein dirt.

即,本发明的目的并不是像上述专利文献1-3中记载的方法那样,使含有磷酸胆碱基的单体聚合,制造防蛋白质吸附的隐形眼镜,而是通过对隐形眼镜进行后处理,使其具有优异的防止蛋白质吸附的功能。That is, the purpose of the present invention is not to polymerize phosphorylcholine group-containing monomers to produce contact lenses that prevent protein adsorption as in the methods described in the above-mentioned Patent Documents 1-3, but to post-process the contact lenses to It has an excellent function of preventing protein adsorption.

本发明的目的也不是像专利文献4记载的方法那样,在隐形眼镜的表面使含磷酸胆碱基的单体聚合,用与隐形眼镜不同的另外的聚合物覆盖,由此导入磷酸胆碱基,而是无需聚合物覆盖,直接与磷酸胆碱基共价键合,由此得到耐久性优异,没有因聚合物覆盖而改变隐形眼镜本来的性质,可发挥优异的防止蛋白质吸附的效果。The object of the present invention is not to polymerize a phosphorylcholine group-containing monomer on the surface of a contact lens as in the method described in Patent Document 4, and cover it with another polymer different from the contact lens, thereby introducing a phosphorylcholine group. , instead of covering with a polymer, it is directly covalently bonded to the phosphorylcholine group, thereby obtaining excellent durability, without changing the original properties of the contact lens due to the covering of the polymer, and can exert an excellent effect of preventing protein adsorption.

本发明的目的也不是像引用文献5记载的方法那样,在进行验证试验时,实际无法向隐形眼镜表面充分导入磷酸胆碱基,而是可以导入足够量的磷酸胆碱基,发挥优异的防止蛋白质吸附的效果。The object of the present invention is not that, like the method described in Citation Document 5, it is not possible to introduce enough phosphorylcholine groups into the contact lens surface during the verification test, but it can introduce a sufficient amount of phosphorylcholine groups to exert an excellent preventive effect. The effect of protein adsorption.

特别是,本发明与专利文献5所示方法的本质区别是:本发明中,其特征在于将具有末端氨基的化合物导入眼镜材料的表面,经由该化合物,使低分子量的、式(2)或(3)的含磷酸胆碱基的化合物与隐形眼镜表面化学键合,由此可抑制透镜的变形,同时有效地抑制蛋白的吸附。即,在直接向存在于隐形眼镜表面的官能基团中导入磷酸胆碱基时,由于其高亲水性,透镜稍有膨胀的倾向,但是,通过在透镜表面和磷酸胆碱基之间导入两末端具有氨基的烷基或烷氧基等,可以容易地控制该膨胀。具有氨基的化合物的亲水性越低,则越具有抑制透镜膨胀的效果。烷基链长为0-6时,最优选,可以控制膨胀。为氧化烯基时,链长的影响小。In particular, the essential difference between the present invention and the method shown in Patent Document 5 is that in the present invention, it is characterized in that a compound having terminal amino groups is introduced into the surface of the lens material, and through the compound, the low molecular weight, formula (2) or The phosphorylcholine group-containing compound of (3) is chemically bonded to the contact lens surface, thereby suppressing deformation of the lens and effectively suppressing protein adsorption. That is, when a phosphorylcholine group is directly introduced into a functional group present on the surface of a contact lens, the lens tends to swell slightly due to its high hydrophilicity, but by introducing it between the lens surface and the phosphorylcholine group An alkyl group or an alkoxy group having amino groups at both ends can easily control the expansion. The lower the hydrophilicity of the compound having an amino group, the more effective it is to suppress lens swelling. Alkyl chain lengths of 0-6 are most preferred to control swelling. In the case of an oxyalkylene group, the influence of the chain length is small.

即,本发明提供眼镜材料的制造方法,该方法具有使具有下式(1)所示磷酸胆碱基的化合物与眼镜材料的表面反应而共价键合的工序,其特征在于:将具有末端氨基的化合物导入眼镜材料的表面,接着,经由上述具有末端氨基的化合物导入下式(2)的化合物。That is, the present invention provides a method for producing an eyeglass material, the method having a step of reacting a compound having a phosphorylcholine group represented by the following formula (1) with the surface of the eyeglass material to bond covalently, characterized in that: An amino compound is introduced into the surface of the lens material, and then a compound of the following formula (2) is introduced via the above-mentioned compound having a terminal amino group.

[化5][chemical 5]

[化6][chemical 6]

Figure S05816846320061129D000032
Figure S05816846320061129D000032

n为1-18的自然数n is a natural number from 1 to 18

(2)(2)

本发明还提供眼镜材料的制造方法,该眼镜材料的制造方法具有使具有下式(1)所示磷酸胆碱基的化合物与眼镜材料的表面反应而共价键合的工序,其特征在于:将具有末端氨基的化合物导入眼镜材料的表面,然后经由上述具有末端氨基的化合物导入下式(3)的含磷酸胆碱基的化合物。The present invention also provides a method for producing a spectacle material, which has a step of reacting a compound having a phosphorylcholine group represented by the following formula (1) with the surface of the spectacle material to form a covalent bond, which is characterized in that: A compound having a terminal amino group is introduced into the surface of a lens material, and then a phosphorylcholine group-containing compound of the following formula (3) is introduced via the compound having a terminal amino group.

[化7][chemical 7]

Figure S05816846320061129D000041
Figure S05816846320061129D000041

[化8][chemical 8]

本发明叉提供上述眼镜材料的制造方法,其特征在于:上述具有末端氨基的化合物是具有C0(肼)~C12的烷基、聚合度为1~10的环氧乙烷基、聚合度为1~10的环氧丙烷基、聚合度为1~20的吖丙啶、聚合度为1~20的2-甲基吖丙啶的化合物,具有哌嗪、或苯胺的化合物。The present invention provides the manufacturing method of the above-mentioned spectacle material, characterized in that: the above-mentioned compound with terminal amino group is an alkyl group having C0 (hydrazine) to C12, an oxirane group with a degree of polymerization of 1 to 10, and a degree of polymerization of 1 A compound having a propylene oxide group of ~10, an aziridine with a degree of polymerization of 1 to 20, a compound of 2-methyl aziridine with a degree of polymerization of 1 to 20, a compound having piperazine or aniline.

本发明还提供防止眼镜材料吸附蛋白质的方法,其特征在于:向眼镜材料的表面导入具有末端氨基的化合物,接着通过使上述含磷酸胆碱基的化合物与眼镜材料反应的后处理,使磷酸胆碱基与眼镜材料的表面共价键合,防止蛋白质对眼镜材料的吸附。The present invention also provides a method for preventing protein adsorption by lens materials, which is characterized in that: a compound having terminal amino groups is introduced into the surface of the lens materials, and then the phosphorylcholine group is converted into phosphorylcholine The base is covalently bonded to the surface of the lens material, preventing the adsorption of proteins to the lens material.

本发明又提供防止眼镜材料吸附蛋白质的方法,其特征在于:向上式(2)或(3)的含磷酸胆碱基的化合物中导入氨基,接着通过使其与眼镜材料的表面反应的处理,使磷酸胆碱基与眼镜材料的表面共价键合,防止蛋白质对眼镜材料的吸附。The present invention also provides a method for preventing protein adsorption of lens materials, which is characterized in that: amino groups are introduced into the phosphorylcholine group-containing compound of the upward formula (2) or (3), and then reacted with the surface of the lens material, The phosphorylcholine group is covalently bonded to the surface of the lens material to prevent the adsorption of protein to the lens material.

本发明还提供眼镜材料,该眼镜材料是通过酰胺键或烷胺键,向眼镜材料的表面与导入的上式(2)或(3)的具有磷酸胆碱基的化合物之间导入间隔基团。The present invention also provides an eyeglass material, which introduces a spacer group between the surface of the eyeglass material and the imported compound having a phosphorylcholine group of formula (2) or (3) through an amide bond or an alkylamine bond .

根据本发明的制造方法,可通过简便的后处理方法,经由具有末端氨基的化合物,使任意量的磷酸胆碱基与眼镜材料的表面共价键合。According to the production method of the present invention, any amount of phosphorylcholine groups can be covalently bonded to the surface of the lens material through a compound having a terminal amino group by a simple post-treatment method.

本发明的眼镜材料——隐形眼镜是经由具有末端氨基的化合物,使磷酸胆碱基与隐形眼镜表面共价键合,因此有效抑制蛋白质吸附隐形眼镜,发挥优异的防污垢效果。还可提高保水性,也可提高佩戴感。The lens material of the present invention, the contact lens, covalently bonds the phosphorylcholine group to the surface of the contact lens through a compound having an amino terminal group, thereby effectively inhibiting protein adsorption to the contact lens and exerting an excellent antifouling effect. It also improves water retention and improves wearing comfort.

另外,是通过后处理而具有防蛋白质吸附功能,因此可以在现有的隐形眼镜中容易地利用本发明。In addition, since the protein adsorption prevention function is provided by the post-treatment, the present invention can be easily applied to existing contact lenses.

并不是通过聚合物覆盖导入磷酸胆碱基,因此耐久性优异,基本上不会使隐形眼镜本来的性质变差。The introduction of phosphorylcholine groups is not covered by polymers, so the durability is excellent, and the original properties of contact lenses are basically not deteriorated.

由本发明得到的隐形眼镜是佩戴感优异的隐形眼镜。因此,优选用于因为材质的柔软性差等理由而容易感到异物感的隐形眼镜中。The contact lens obtained by this invention is a contact lens excellent in wearing feeling. Therefore, it is preferably used in contact lenses that tend to feel a foreign body sensation due to reasons such as poor flexibility of the material.

特别是具有末端氨基的化合物和式(2)以及式(3)的化合物的反应的收率极好,容易控制导入量。因此,具有可以以极高效率向隐形眼镜表面导入式(1)的磷酸胆碱基的优异的效果。In particular, the reaction yields of compounds having terminal amino groups with compounds of formula (2) and formula (3) are excellent, and it is easy to control the introduction amount. Therefore, there is an excellent effect that the phosphorylcholine group of the formula (1) can be introduced into the contact lens surface with extremely high efficiency.

根据本方法,还可以抑制透镜的变形,同时有效抑制蛋白的吸附。即,直接向存在于隐形眼镜表面的官能基团导入亲水性高的官能团时,透镜稍有膨胀倾向,但是通过在透镜表面和磷酸胆碱基之间选择两末端具有氨基的官能基团,控制其极性,可以容易地控制其膨胀。According to this method, the deformation of the lens can also be suppressed, and at the same time, the adsorption of proteins can be effectively suppressed. That is, when a highly hydrophilic functional group is directly introduced into a functional group existing on the surface of a contact lens, the lens tends to swell slightly, but by selecting a functional group having amino groups at both ends between the lens surface and the phosphorylcholine group, By controlling its polarity, its expansion can be easily controlled.

附图简述Brief description of the drawings

图1是实施例和比较例的隐形眼镜的蛋白质吸附量的图表。FIG. 1 is a graph of protein adsorption amounts of contact lenses of Examples and Comparative Examples.

具体实施方式Detailed ways

以下详细说明本发明。The present invention will be described in detail below.

“具有末端氨基的化合物”"Compounds with a terminal amino group"

本发明所使用的具有氨基的化合物有:肼、乙二胺、丙二胺、1,4-二氨基丁烷、1,6-二氨基己烷、哌嗪、乙二醇二(2-氨基乙基)醚、乙二醇二(3-氨基丙基)醚等,以上各种均可作为试剂购入。其极性也是在可防止膨胀的范围内的。另外,三(2-氨基乙基)胺或氨基末端树枝状高分子等具有三个或以上末端氨基的化合物也可以有效地用作本发明中使用的具有氨基的化合物。The compounds with amino groups used in the present invention are: hydrazine, ethylenediamine, propylenediamine, 1,4-diaminobutane, 1,6-diaminohexane, piperazine, ethylene glycol bis(2-amino Ethyl) ether, ethylene glycol bis(3-aminopropyl) ether, etc., all of the above can be purchased as reagents. Its polarity is also within a range that prevents swelling. In addition, compounds having three or more terminal amino groups such as tris(2-aminoethyl)amine or amino-terminal dendrimers can also be effectively used as the compound having amino groups used in the present invention.

“式(2)的含磷酸胆碱基的化合物的制备方法”"Method for preparing phosphorylcholine group-containing compound of formula (2)"

磷酸胆碱基可以完全合成。但是,合成条件复杂,必须是严格的无水条件,制造成本高。Phosphorylcholine can be completely synthesized. However, the synthesis conditions are complicated, must be strict anhydrous conditions, and the production cost is high.

另一方面,磷酸胆碱可以以细胞膜的构成成分——卵磷脂的形式提取,这种情况下,通过水解除去脂肪酸部分,可以更低成本且容易地获得1-α-甘油磷酸胆碱。本发明人发现通过将该1-α-甘油磷酸胆碱的二醇部分氧化性开裂,容易地获得了具有羧基的含磷酸胆碱基的化合物。On the other hand, phosphorylcholine can be extracted in the form of lecithin, which is a constituent of the cell membrane. In this case, 1-α-glycerophosphocholine can be obtained easily and at a lower cost by removing the fatty acid moiety by hydrolysis. The inventors of the present invention have found that a carboxyl-containing phosphorylcholine group-containing compound can be easily obtained by oxidatively cleaving the diol portion of this 1-α-glycerophosphorylcholine.

最具代表性的合成方法是:将1-α-甘油磷酸胆碱在水和乙腈等溶剂中,通过高碘酸钠和三氯化钌进行氧化,得到目标羧基化合物。The most representative synthesis method is: oxidizing 1-α-glycerophosphorylcholine in water, acetonitrile and other solvents with sodium periodate and ruthenium trichloride to obtain the target carboxyl compound.

式(2)的化合物优选使用由1-α-甘油磷酸胆碱氧化开裂得到的羧基甲基磷酸胆碱(n=1时)。The compound of formula (2) is preferably carboxymethylphosphorylcholine obtained by oxidative cleavage of 1-α-glycerophosphorylcholine (when n=1).

“通过1-α-甘油磷酸胆碱的氧化开裂制备羧基甲基磷酸胆碱的方法”"Preparation of carboxymethylphosphorylcholine by oxidative cleavage of 1-alpha-glycerophosphorylcholine"

1-α-甘油磷酸胆碱可在水、乙腈混合溶剂中,通过高碘酸盐和三氯化钌进行氧化开裂,制成羧基甲基磷酸胆碱。1-α-Glycerophosphorylcholine can be oxidized and cracked by periodate and ruthenium trichloride in a mixed solvent of water and acetonitrile to produce carboxymethylphosphorylcholine.

即,如实施例所示,将5g 1-α-甘油磷酸胆碱溶解于70ml水-30ml乙腈中。冰冷却下添加17g高碘酸钠和80mg三氯化钌,搅拌过夜,过滤沉淀物,减压浓缩,通过甲醇萃取得到3.86g(收率82%)目标羧基甲基磷酸胆碱。That is, as shown in Examples, 5 g of 1-α-glycerophosphorylcholine was dissolved in 70 ml of water-30 ml of acetonitrile. 17g of sodium periodate and 80mg of ruthenium trichloride were added under ice-cooling, stirred overnight, the precipitate was filtered, concentrated under reduced pressure, and extracted with methanol to obtain 3.86g (yield 82%) of the target carboxymethylphosphorylcholine.

“式(3)的含磷酸胆碱基的化合物的制备方法”"Method for preparing phosphorylcholine group-containing compound of formula (3)"

通过公知的方法,对公知的甘油磷酸胆碱进行氧化开裂。例如,使用高碘酸、高碘酸盐、或三氧化铋等氧化剂,对1,2-二醇进行氧化,使键开裂,可得到醛体。反应通常在水中或含水的有机溶剂中进行,反应温度为0℃~室温。在水中经过平衡反应,醛体也形成水合物,这对接下来的与胺的反应没有影响。以下给出制备含有磷酸胆碱基的单官能醛体流程的一个例子。Oxidative cleavage of the known glycerophosphorylcholine is performed by known methods. For example, 1,2-diol is oxidized using an oxidizing agent such as periodic acid, periodate, or bismuth trioxide to cleave the bond to obtain an aldehyde. The reaction is usually carried out in water or an organic solvent containing water, and the reaction temperature is from 0°C to room temperature. After an equilibrium reaction in water, the aldehyde body also forms a hydrate, which has no effect on the subsequent reaction with the amine. An example of a scheme for the preparation of monofunctional aldehydes containing phosphorylcholine groups is given below.

[化13][chemical 13]

Figure S05816846320061129D000071
Figure S05816846320061129D000071

“眼镜材料”"glass material"

本发明中,眼镜材料是佩戴在眼睛中的材料的成型品。主要是隐形眼镜。可以是任何材质的隐形眼镜。例如由以下隐形眼镜均可以制造本发明的隐形眼镜:即,由甲基丙烯酸(MAA)、丙烯酸(AA)、甲基丙烯酸2-羟基乙酯(HEMA)、N-乙烯基吡咯烷酮(NVP)、N,N-二甲基丙烯酰胺(DMAA)、乙烯醇(VA)、甲基丙烯酸甲酯(MMA)、甲基丙烯酸三氟乙酯(TFEMA)、乙酸丁酸纤维(CAB)、氟硅氧烷、甲基丙烯酸六氟异丙酯、甲基丙烯酸全氟烷基酯、甲基丙烯酸硅氧烷基(シロキサニル)酯(SiMA)、硅氧烷基苯乙烯(SiSt)、二甲基丙烯酸乙二醇酯(EGDMA)、甲基丙烯酸烯丙酯(AMA)、有机硅大分子单体等的聚合物或两种或以上单体的共聚物构成。In the present invention, the spectacle material is a molded product of a material worn in eyes. Mainly contact lenses. Contact lenses can be of any material. For example, the contact lenses of the present invention can be manufactured from the following contact lenses: namely, from methacrylic acid (MAA), acrylic acid (AA), 2-hydroxyethyl methacrylate (HEMA), N-vinylpyrrolidone (NVP), N, N-dimethylacrylamide (DMAA), vinyl alcohol (VA), methyl methacrylate (MMA), trifluoroethyl methacrylate (TFEMA), cellulose acetate butyrate (CAB), fluorosilicone alkane, hexafluoroisopropyl methacrylate, perfluoroalkyl methacrylate, siloxane methacrylate (Siloxanil) ester (SiMA), siloxane styrene (SiSt), ethyl dimethacrylate Polymers of glycol esters (EGDMA), allyl methacrylate (AMA), silicone macromers, etc., or copolymers of two or more monomers.

作为构成隐形眼镜的单体,以甲基丙烯酸2-羟基乙酯为主要成分的软性隐形眼镜、以及使甲基丙烯酸与其共聚得到的离子性软性隐形眼镜是代表性的软性隐形眼镜,蛋白质容易吸附。因此优选通过本发明的方法处理。As monomers constituting contact lenses, soft contact lenses mainly composed of 2-hydroxyethyl methacrylate and ionic soft contact lenses obtained by copolymerizing methacrylic acid are typical soft contact lenses. Proteins are easily adsorbed. Treatment by the method of the invention is therefore preferred.

本发明所优选的单体是丙烯酸或甲基丙烯酸。如果构成隐形眼镜的单体中含有丙烯酸或甲基丙烯酸,由于隐形眼镜表面具有羧基,因此通过酰胺键可容易地将上述具有两末端氨基的化合物导入。The preferred monomers of this invention are acrylic acid or methacrylic acid. If acrylic acid or methacrylic acid is contained in the monomer constituting the contact lens, since the surface of the contact lens has a carboxyl group, the above-mentioned compound having amino groups at both terminals can be easily introduced through an amide bond.

即使是不存在羧基的隐形眼镜,通过表面改性剂或等离子体处理也可以导入羧基。通过等离子体处理的具体导入方法如下所示。Even in contact lenses without carboxyl groups, carboxyl groups can be introduced by surface modifiers or plasma treatment. The specific introduction method by plasma treatment is as follows.

<通过等离子体处理的表面反应导入羧基><Introduction of Carboxyl Groups by Surface Reaction by Plasma Treatment>

在二氧化碳气氛下,通过低温等离子体向隐形眼镜表面导入羧基。具体来说,将隐形眼镜装入等离子体反应容器内,用真空泵将反应容器内抽真空,然后导入二氧化碳。接着进行辉光放电,可向隐形眼镜表面导入羧基。Carboxyl groups are introduced to the surface of contact lenses by low-temperature plasma in a carbon dioxide atmosphere. Specifically, a contact lens is put into a plasma reaction container, the inside of the reaction container is evacuated by a vacuum pump, and then carbon dioxide is introduced. Then, glow discharge is performed, and carboxyl groups can be introduced into the surface of the contact lens.

“制备方法”"Preparation"

首先,通过常规方法使具有末端氨基的化合物与隐形眼镜构成单体的羧基或者通过等离子体处理等新向隐形眼镜表面后导入的羧基共价键合(酰胺键)。First, a compound having a terminal amino group is covalently bonded (amide bond) to a carboxyl group of a contact lens constituting monomer or a carboxyl group newly introduced to the surface of a contact lens by plasma treatment or the like by a conventional method.

具体来说,将poly-HEMA制造的隐形眼镜装在等离子体反应容器(サムコインタ一ナシヨナル研究所制造BP-1)中,将容器内的空气完全置换为二氧化碳,在室温下进行10分钟阳极处理(RFPower100),导入羧基。接着,将在羰基二咪唑或1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐等碳二亚胺系偶联剂,或者亚硫酰氯、五氯化磷、磷酰氯、三溴化磷、草酰氯等存在下进行处理的隐形眼镜浸渍在过量含有具有两末端氨基的化合物的水或有机溶剂中,进行酰胺化反应,向末端导入氨基,然后洗涤。Specifically, contact lenses made of poly-HEMA were placed in a plasma reaction vessel (BP-1 manufactured by SamCointa Nashiyonal Research Institute), the air in the vessel was completely replaced with carbon dioxide, and anodic treatment was carried out at room temperature for 10 minutes ( RFPower100), import carboxyl group. Next, carbonyldiimidazole or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and other carbodiimide coupling agents, or thionyl chloride, pentachloride Contact lenses treated in the presence of phosphorus, phosphorus oxychloride, phosphorus tribromide, oxalyl chloride, etc. are immersed in water or an organic solvent containing an excess of a compound having amino groups at both terminals, undergo amidation reaction, introduce amino groups to the terminals, and then wash.

接着,使式(2)或(3)的化合物与未反应的氨基进行酰胺键合。Next, the compound of formula (2) or (3) is amide bonded to the unreacted amino group.

具体来说,为式(2)的化合物时,将(2)化合物溶解或分散于水或者N,N-二甲基甲酰胺、乙腈、二甲基亚砜等有机溶剂中,添加羰基二咪唑或1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐等碳二亚胺系偶联剂,或者亚硫酰氯等,制成活性酯或酰氯化物,与隐形眼镜的氨基表面进行酰胺化反应。Specifically, when it is a compound of formula (2), dissolve or disperse the compound (2) in water or organic solvents such as N, N-dimethylformamide, acetonitrile, dimethyl sulfoxide, and add carbonyldiimidazole Or 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide coupling agent such as carbodiimide hydrochloride, or thionyl chloride, etc., to make active ester or acid chloride, and Amino surface of contact lenses undergoes amidation reaction.

为式(3)的化合物时,将(3)化合物溶解于水或甲醇等质子性溶剂或含有这些物质的溶剂中,浸渍隐形眼镜,反应4小时,再添加氰基硼酸钠,搅拌过夜,然后洗涤。When it is a compound of formula (3), the compound of (3) is dissolved in protic solvents such as water or methanol or solvents containing these substances, the contact lens is immersed, reacted for 4 hours, then sodium cyanoborate is added, stirred overnight, and then washing.

结果,经由具有末端氨基的化合物,可以向隐形眼镜的表面导入式(1)的磷酸胆碱基。As a result, the phosphorylcholine group of the formula (1) can be introduced into the surface of the contact lens via the compound having the terminal amino group.

关于具有两末端氨基的化合物的导入,只要是在记载的范围内,均可以在相同条件下反应。The introduction of a compound having amino groups at both terminals can be reacted under the same conditions as long as it is within the described range.

也可以通过等离子体处理向隐形眼镜中直接导入氨基。公知的方法如以下所示。Amino groups can also be directly introduced into contact lenses by plasma treatment. Known methods are as follows.

<通过等离子体处理的表面反应导入氨基><Introduction of amino group by surface reaction of plasma treatment>

在氮气气氛下,通过低温等离子体向隐形眼镜表面导入氨基。具体来说,将隐形眼镜装入等离子体反应容器内,用真空泵使反应容器内抽真空,然后导入氮气。接着,可通过辉光放电向透镜表面导入氨基。关于等离子体处理的有关文献如下所示。Amino groups are introduced to the contact lens surface by low-temperature plasma under nitrogen atmosphere. Specifically, contact lenses were placed in a plasma reaction container, the inside of the reaction container was evacuated by a vacuum pump, and then nitrogen gas was introduced. Next, amino groups can be introduced to the lens surface by glow discharge. The relevant literature on plasma treatment is listed below.

1.M.Muller,C.oehr1. M. Muller, C. oehr

Plasma aminofunctionalisation of PVDF microfiltration membranes:comparison ofthe in plasma modifications with a grafting method using ESCA and anamino-selective fluorescent probeSurface and Coatings Technology 116-119(1999)802-807Plasma aminofunctionalisation of PVDF microfiltration membranes: comparison ofthe in plasma modifications with a grafting method using ESCA and anamino-selective fluorescent probeSurface and Coatings Technology 116-119(1999)802-807

2.Lidija Tusek,Mirko Nitschke,Carsten Werner,Karin Stana-Kleinschek,VolkerRibitsch2. Lidija Tusek, Mirko Nitschke, Carsten Werner, Karin Stana-Kleinschek, Volker Ribitsch

Surface characterization of NH3 plasma treated polyamide 6 foilsColloids and Surfaces A:Physicochem.Eng.Aspects 195(2001)81-95Surface characterization of NH3 plasma treated polyamide 6 foilsColloids and Surfaces A: Physicochem.Eng.Aspects 195(2001)81-95

3.Fabienne Poncin-Epaillard,Jean-Claude Brosse,Thierry FalherReactivity of surface groups formed onto a plasma treated poly(propylene)filmMacromol.Chem.Phys.200.989-996(1999)3. Fabienne Poncin-Epaillard, Jean-Claude Brosse, Thierry FalherReactivity of surface groups formed onto a plasma treated poly(propylene) filmMacromol.Chem.Phys.200.989-996(1999)

实施例Example

下面,根据实施例进一步详细说明本发明。本发明并不受这些实施例的限定。Hereinafter, the present invention will be described in further detail based on examples. The present invention is not limited by these Examples.

“式(2)的化合物的合成”"Synthesis of compounds of formula (2)"

将5g 1-α-甘油磷酸胆碱溶解于70ml水-30ml乙腈。冰冷却下添加17g高碘酸钠和80mg三氯化钌,搅拌过夜。过滤沉淀物,减压浓缩,通过甲醇萃取得到3.86g(收率82%)目标羧基甲基磷酸胆碱。Dissolve 5g of 1-α-glycerophosphorylcholine in 70ml of water-30ml of acetonitrile. Add 17 g of sodium periodate and 80 mg of ruthenium trichloride under ice cooling, and stir overnight. The precipitate was filtered, concentrated under reduced pressure, and extracted with methanol to obtain 3.86 g (yield 82%) of the target carboxymethylphosphorylcholine.

羧基甲基磷酸胆碱是n=1时的式(2)的化合物。Carboxymethylphosphorylcholine is a compound of formula (2) when n=1.

“式(3)的化合物的合成”"Synthesis of compounds of formula (3)"

将450mg 1-α-甘油磷酸胆碱溶解于15ml蒸馏水,在冰水浴中冷却。添加750mg高碘酸钠,搅拌5小时。将反应液减压浓缩,减压干燥,通过甲醇萃取目标物质。Dissolve 450mg of 1-α-glycerophosphorylcholine in 15ml of distilled water and cool in an ice-water bath. Add 750 mg of sodium periodate, and stir for 5 hours. The reaction solution was concentrated under reduced pressure, dried under reduced pressure, and the target substance was extracted with methanol.

“实施例1”<具有式(2)的化合物的隐形眼镜(间隔基团:乙二胺)>"Example 1" <Contact lens having compound of formula (2) (spacer: ethylenediamine)>

将1片市售的软性隐形眼镜EtafilconA(商品名ワンデ一アキユビユ一、J&J制造、构成单体:HEMA-MAA)浸渍在3ml水中,添加30mg乙二胺、10mg 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐、6mg N-羟基琥珀酰亚胺,在室温下搅拌3小时。将隐形眼镜用纯水充分洗涤,浸渍在3ml水中,然后添加10mg化学式(2)的化合物、10mg 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐、6mg N-羟基琥珀酰亚胺,在室温下搅拌3小时,然后用水充分洗涤,得到目标磷酸胆碱基与表面化学键合的隐形眼镜。One piece of commercially available soft contact lens Etafilcon A (trade name Wande Akuubiya, manufactured by J&J, constituent monomer: HEMA-MAA) was immersed in 3 ml of water, and 30 mg of ethylenediamine, 10 mg of 1-ethyl-3-( 3-dimethylaminopropyl) carbodiimide hydrochloride, 6mg N-hydroxysuccinimide, stirred at room temperature for 3 hours. The contact lens was thoroughly washed with pure water, immersed in 3 ml of water, and then 10 mg of the compound of chemical formula (2), 10 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 6 mg of N-hydroxysuccinimide, stirred at room temperature for 3 hours, and then washed thoroughly with water to obtain a contact lens in which the target phosphorylcholine group is chemically bonded to the surface.

“实施例2”<具有式(3)的化合物的隐形眼镜(间隔基团:乙二胺)>"Example 2" <Contact lens having compound of formula (3) (spacer: ethylenediamine)>

将1片市售软性隐形眼镜EtafilconA(商品名ワンデ一アキユビユ一、J&J制造、构成单体:HEMA-MAA)浸渍在3ml水中,添加30mg乙二胺、10mg 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐、6mgN-羟基琥珀酰亚胺,在室温下搅拌3小时。将隐形眼镜用纯水充分洗涤,浸渍在3ml水中,然后添加10mg化学式(3)的化合物,在室温下搅拌4小时,然后添加3mg氰基硼酸钠,搅拌过夜,用水充分洗涤,得到目标磷酸胆碱基与表面化学键合的隐形眼镜。One piece of commercially available soft contact lens Etafilcon A (trade name Wanda Akuyubi, manufactured by J&J, constituent monomer: HEMA-MAA) was immersed in 3 ml of water, and 30 mg of ethylenediamine, 10 mg of 1-ethyl-3-(3 -Dimethylaminopropyl) carbodiimide hydrochloride, 6 mg of N-hydroxysuccinimide, stirred at room temperature for 3 hours. Fully wash the contact lens with pure water, immerse it in 3ml of water, then add 10mg of the compound of chemical formula (3), stir at room temperature for 4 hours, then add 3mg of sodium cyanoborate, stir overnight, and fully wash with water to obtain the target phosphoric acid chol Contact lenses with bases chemically bonded to the surface.

“实施例3”<具有式(2)的化合物的隐形眼镜(间隔基团:1,6-二氨基己烷)>"Example 3" <Contact lens having compound of formula (2) (spacer: 1,6-diaminohexane)>

将1片市售的软性隐形眼镜EtafilconA(商品名ワンデ一アキユビユ一、J&J制造、构成单体:HEMA-MAA)浸渍在3ml N,N-二甲基甲酰胺中,添加50mg 1,6-二氨基己烷、10mg 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐、6mg N-羟基琥珀酰亚胺,在室温下搅拌3小时。将隐形眼镜用N,N-二甲基甲酰胺充分洗涤,浸渍在3ml N,N-二甲基甲酰胺中,然后将10mg化学式(2)的化合物与1ml将6mg亚硫酰氯在N,N-二甲基甲酰胺中搅拌30分钟所得的溶液混合,反应4小时,用水充分洗涤,得到目标磷酸胆碱基与表面化学键合的隐形眼镜。One piece of commercially available soft contact lens Etafilcon A (trade name WANDA アキユビュ, manufactured by J&J, constituent monomer: HEMA-MAA) was immersed in 3 ml of N,N-dimethylformamide, and 50 mg of 1,6- Diaminohexane, 10 mg 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, 6 mg N-hydroxysuccinimide, stirred at room temperature for 3 hours. The contact lens is fully washed with N,N-dimethylformamide, immersed in 3ml N,N-dimethylformamide, then the compound of 10mg chemical formula (2) and 1ml will 6mg thionyl chloride in N,N - Stirring in dimethylformamide for 30 minutes and mixing the resulting solutions, reacting for 4 hours, and washing thoroughly with water to obtain a contact lens in which the target phosphorylcholine group is chemically bonded to the surface.

“实施例4”<具有式(2)的化合物的隐形眼镜(隔离基团:乙二醇二(2-氨基乙基)醚)>"Example 4" <Contact lens having compound of formula (2) (separating group: ethylene glycol bis(2-aminoethyl) ether)>

将1片市售的软性隐形眼镜EtafilconA(商品名ワンデ一アキユビユ一、J&J制造、构成单体:HEMA-MAA)浸渍在3ml N,N-二甲基甲酰胺中,添加62mg乙二醇二(2-氨基乙基)醚、10mg 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐、6mg N-羟基琥珀酰亚胺,在室温下搅拌3小时。将隐形眼镜用N,N-二甲基甲酰胺充分洗涤,浸渍在3ml N,N-二甲基甲酰胺中,然后将10mg化学式(2)的化合物与1ml将6mg亚硫酰氯在N,N-二甲基甲酰胺中搅拌30分钟所得的溶液混合,反应4小时,用水充分洗涤,得到目标磷酸胆碱基与表面化学键合的隐形眼镜。One piece of commercially available soft contact lens Etafilcon A (trade name Wande Akuyubiyu, manufactured by J&J, constituent monomer: HEMA-MAA) was immersed in 3 ml of N,N-dimethylformamide, and 62 mg of ethylene glycol diol was added. (2-aminoethyl) ether, 10mg 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, 6mg N-hydroxysuccinimide, stirred at room temperature for 3 hours . The contact lens is fully washed with N,N-dimethylformamide, immersed in 3ml N,N-dimethylformamide, then the compound of 10mg chemical formula (2) and 1ml will 6mg thionyl chloride in N,N - Stirring in dimethylformamide for 30 minutes and mixing the resulting solutions, reacting for 4 hours, and washing thoroughly with water to obtain a contact lens in which the target phosphorylcholine group is chemically bonded to the surface.

“比较例1~5”"Comparative examples 1 to 5"

使用下述市售商品的隐形眼镜作为比较品。The following commercially available contact lenses were used as comparative products.

比较例1.EtafilconA(商品名:ワンデ一アキユビユ一、J&J制造)Comparative Example 1. Etafilcon A (trade name: Wonder Akubiyu, manufactured by J&J)

比较例2.EtafilconA(商品名:ワンデ一アクエア一、オキユラ一サイエンス制造)Comparative Example 2. Etafilcon A (trade name: manufactured by Wonder Aqua A, Okiura Cyence)

比较例3.NelfilconA(商品名:フオ一カスデイリイ一ズ、チバビジヨン制造)Comparative Example 3. Nelfilcon A (trade name: Fokas Dairy Izu, manufactured by Chiba Bijinyon)

比较例4.Polymacon(商品名:メダリスト、ボシユロム制造)Comparative Example 4. Polymacon (trade name: Medallist, manufactured by Boshilum)

比较例5.VifilconA(商品名:フオ一カス、チバビジヨン制造)Comparative Example 5. Vifilcon A (trade name: Fo-Kas, manufactured by Chibabijiyon)

比较例6.比较实施例1Comparative Example 6. Comparative Example 1

比较例7.比较实施例2Comparative Example 7. Comparative Example 2

“比较例6”"Comparative Example 6"

根据专利文献5的方法,将10mg 1-α-甘油磷酸胆碱、20mg 1,1-羰基二咪唑、20mg三乙胺添加到3ml二甲基亚砜中,在50℃搅拌2小时。将实施例1中使用的Polymacon浸渍在该溶液中,在室温下反应12小时。将隐形眼镜先用二甲基亚砜、接着用水充分洗涤,进行磷定量,导入的磷酸胆碱基是检测下限0.0001μmol/mg以下,反应未进行。According to the method of Patent Document 5, 10 mg of 1-α-glycerophosphorylcholine, 20 mg of 1,1-carbonyldiimidazole, and 20 mg of triethylamine were added to 3 ml of dimethyl sulfoxide, and stirred at 50°C for 2 hours. The Polymacon used in Example 1 was immersed in this solution and reacted at room temperature for 12 hours. The contact lens was thoroughly washed with dimethyl sulfoxide and then water, and phosphorus was quantified. The introduced phosphorylcholine group was below the detection limit of 0.0001 μmol/mg, and the reaction did not proceed.

“比较例7”"Comparative Example 7"

根据专利文献5的方法,将10mg 1-α-甘油磷酸胆碱、20mg 1,1-羰基二咪唑、20mg三乙胺添加到3ml二甲基亚砜中,在50℃搅拌2小时。将实施例2中使用的NelfilconA浸渍在该溶液中,在室温下反应12小时。将隐形眼镜用二甲基亚砜、接着用水充分洗涤,进行磷定量,导入的磷酸胆碱基为检测下限0.0001μmol/mg以下,反应未进行。According to the method of Patent Document 5, 10 mg of 1-α-glycerophosphorylcholine, 20 mg of 1,1-carbonyldiimidazole, and 20 mg of triethylamine were added to 3 ml of dimethyl sulfoxide, and stirred at 50°C for 2 hours. Nelfilcon A used in Example 2 was immersed in this solution and reacted at room temperature for 12 hours. The contact lens was thoroughly washed with dimethyl sulfoxide, followed by water, and phosphorus was quantified. The introduced phosphorylcholine group was below the detection limit of 0.0001 μmol/mg, and the reaction did not proceed.

实施例1~4、比较例1~7的蛋白质吸附结果如图1所示。由该结果可知:本发明的隐形眼镜显著抑制蛋白质的吸附。The protein adsorption results of Examples 1-4 and Comparative Examples 1-7 are shown in FIG. 1 . From this result, it can be seen that the contact lens of the present invention significantly suppresses protein adsorption.

产业实用性Industrial applicability

根据本发明,可以高度抑制蛋白质吸附隐形眼镜,显著防止蛋白质污垢。According to the present invention, protein adsorption to contact lenses can be highly suppressed, and protein soiling can be remarkably prevented.

本发明的方法优选利用于蛋白质污垢会导致致命问题的软性隐形眼镜中。特别优选利用于促进蛋白质吸附的离子性软性隐形眼镜中。The method of the present invention is preferably utilized in soft contact lenses where protein fouling is a fatal problem. It is particularly preferably utilized in ionic soft contact lenses that promote protein adsorption.

Claims (6)

1.隐形眼镜的处理方法,该隐形眼镜的处理方法具有使具有下式(1)所示磷酸胆碱基的化合物与隐形眼镜的表面反应而共价键合的工序,其特征在于:将具有末端氨基的化合物导入隐形眼镜的表面,接着,经由上述具有末端氨基的化合物导入下式(2)的含磷酸胆碱基的化合物,1. The treatment method of contact lens, the treatment method of this contact lens has the operation that makes the compound with phosphorylcholine group shown in following formula (1) react with the surface of contact lens and covalently bond, it is characterized in that: will have The compound of the terminal amino group is introduced into the surface of the contact lens, and then, the phosphorylcholine group-containing compound of the following formula (2) is introduced via the above-mentioned compound having the terminal amino group, 2.隐形眼镜的处理方法,该隐形眼镜的处理方法具有使具有下式(1)所示磷酸胆碱基的化合物与隐形眼镜的表面反应而共价键合的工序,其特征在于:将具有末端氨基的化合物导入隐形眼镜的表面,接着经由上述具有末端氨基的化合物导入下式(3)的含磷酸胆碱基的化合物,2. The treatment method of contact lens, the treatment method of this contact lens has the operation that makes the compound that has the phosphorylcholine group shown in following formula (1) react with the surface of contact lens and covalently bond, it is characterized in that: will have The compound of the terminal amino group is introduced into the surface of the contact lens, and then the phosphorylcholine group-containing compound of the following formula (3) is introduced via the above-mentioned compound having the terminal amino group,
Figure FSB00000581236700021
Figure FSB00000581236700021
3.权利要求1或2的隐形眼镜的处理方法,其特征在于:上述具有末端氨基的化合物是具有C0~C12的烷基、聚合度为1~10的环氧乙烷基、聚合度为1~10的环氧丙烷基、聚合度为1~20的吖丙啶或聚合度为1~20的2-甲基吖丙啶的化合物。3. The treatment method of contact lenses according to claim 1 or 2, characterized in that: the above-mentioned compound having terminal amino groups is an alkyl group having C0 to C12, an oxirane group having a degree of polymerization of 1 to 10, and a degree of polymerization of 1 A compound having a propylene oxide group of ~10, an aziridine with a degree of polymerization of 1 to 20, or a compound of 2-methyl aziridine with a degree of polymerization of 1 to 20. 4.防止隐形眼镜吸附蛋白质的方法,其特征在于:向隐形眼镜的表面导入具有末端氨基的化合物,接着通过使下式(2)或(3)的含磷酸胆碱基的化合物与隐形眼镜反应的后处理,使磷酸胆碱基与隐形眼镜的表面共价键合,防止蛋白质对隐形眼镜的吸附,4. The method for preventing contact lens from adsorbing proteins is characterized in that: the surface of the contact lens is introduced into a compound with terminal amino groups, and then by making the phosphorylcholine-containing compound of the following formula (2) or (3) react with the contact lens post-treatment to make the phosphorylcholine group covalently bonded to the surface of the contact lens to prevent the adsorption of protein to the contact lens, 5.防止隐形眼镜吸附蛋白质的方法,其特征在于:向下式(2)或(3)的含磷酸胆碱基的化合物中导入氨基,接着通过与隐形眼镜的表面反应的处理,使磷酸胆碱基与隐形眼镜的表面共价键合,防止蛋白质对隐形眼镜的吸附,5. The method that prevents contact lens from adsorbing protein is characterized in that: introduce amino group in the phosphorylcholine group-containing compound of downward formula (2) or (3), then by the processing that reacts with the surface of contact lens, make phosphorylcholine The base is covalently bonded to the surface of the contact lens, preventing the adsorption of the protein to the contact lens, 6.隐形眼镜,其是作为构成隐形眼镜的单体,以甲基丙烯酸2-羟基乙酯为主要成分的软性隐形眼镜、或者使甲基丙烯酸与甲基丙烯酸2-羟基乙酯共聚得到的离子性软性隐形眼镜,其中在其表面上通过具有末端氨基的化合物导入了下式(2)或(3)所示的具有磷酸胆碱基的化合物,6. Contact lenses, which are soft contact lenses mainly composed of 2-hydroxyethyl methacrylate as a monomer constituting contact lenses, or obtained by copolymerizing methacrylic acid and 2-hydroxyethyl methacrylate An ionic soft contact lens, wherein a compound having a phosphorylcholine group represented by the following formula (2) or (3) is introduced on the surface thereof via a compound having a terminal amino group,
Figure FSB00000581236700032
Figure FSB00000581236700032
CN2005800168463A 2004-05-24 2005-05-18 Method for producing protein adsorption-preventing ocular lens material Expired - Fee Related CN1957288B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2004153256 2004-05-24
JP153256/2004 2004-05-24
JP136846/2005 2005-05-10
JP2005136846A JP3738027B2 (en) 2004-05-24 2005-05-10 Method for producing ophthalmic material for preventing protein adsorption
PCT/JP2005/009083 WO2005114305A1 (en) 2004-05-24 2005-05-18 Method for producing protein adsorption-preventing ocular lens material

Publications (2)

Publication Number Publication Date
CN1957288A CN1957288A (en) 2007-05-02
CN1957288B true CN1957288B (en) 2012-01-11

Family

ID=38063734

Family Applications (4)

Application Number Title Priority Date Filing Date
CNB200580016610XA Expired - Fee Related CN100474036C (en) 2004-05-24 2005-05-18 Ocular lens material and method for producing the same
CNB2005800164782A Expired - Fee Related CN100570435C (en) 2004-05-24 2005-05-18 Spectacle material and method for producing same
CNB2005800167884A Expired - Fee Related CN100465700C (en) 2004-05-24 2005-05-18 Lens material preventing protein adsorption and method for producing the same
CN2005800168463A Expired - Fee Related CN1957288B (en) 2004-05-24 2005-05-18 Method for producing protein adsorption-preventing ocular lens material

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CNB200580016610XA Expired - Fee Related CN100474036C (en) 2004-05-24 2005-05-18 Ocular lens material and method for producing the same
CNB2005800164782A Expired - Fee Related CN100570435C (en) 2004-05-24 2005-05-18 Spectacle material and method for producing same
CNB2005800167884A Expired - Fee Related CN100465700C (en) 2004-05-24 2005-05-18 Lens material preventing protein adsorption and method for producing the same

Country Status (1)

Country Link
CN (4) CN100474036C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090295004A1 (en) * 2008-06-02 2009-12-03 Pinsly Jeremy B Silicone hydrogel contact lenses displaying reduced protein uptake
JP4750211B1 (en) * 2010-05-11 2011-08-17 株式会社 資生堂 Surface modification method and surface modification material
CN103739621A (en) * 2010-09-08 2014-04-23 上海生物医学工程研究中心 Application of surface treating agent with phosphorylcholine-like structure in material surface modification
CN103948965B (en) * 2014-04-30 2015-12-09 华南理工大学 A kind of intraocular lens of surface modification and surface modifying method
TWI609703B (en) * 2017-04-10 2018-01-01 明基材料股份有限公司 Ophthalmic lens and manufacturing method thereof
JP7485602B2 (en) * 2018-01-30 2024-05-16 アルコン インク. Contact lenses having a lubricious coating thereon
CN110804104B (en) * 2019-10-30 2021-12-07 暨南大学 Cell membrane bionic surface modified bacterial cellulose and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721800A (en) * 1984-01-20 1988-01-26 Biocompatibles Ltd. Biocompatible surfaces
CN87105002A (en) * 1986-07-18 1988-02-03 奥蒂默斯公司 fluorine-containing soft contact lens hydrogels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3825502B2 (en) * 1996-06-11 2006-09-27 日本油脂株式会社 Modified protein production method and contact lens dirt remover
ATE277109T1 (en) * 1998-07-17 2004-10-15 Biocompatibles Uk Ltd METHOD FOR PRODUCING COATED MOLDED POLYMERIC ARTICLES
JP4772939B2 (en) * 1998-09-29 2011-09-14 日油株式会社 Polymerizable monomer composition and contact lens
JP4691868B2 (en) * 1999-07-14 2011-06-01 日油株式会社 Random copolymer, method for producing the same, and medical material
JP3959676B2 (en) * 2001-11-07 2007-08-15 東洋紡績株式会社 Highly safe polymer composition containing phosphorus-containing polymer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721800A (en) * 1984-01-20 1988-01-26 Biocompatibles Ltd. Biocompatible surfaces
CN87105002A (en) * 1986-07-18 1988-02-03 奥蒂默斯公司 fluorine-containing soft contact lens hydrogels

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JP特开2003-138144A 2003.05.14
JP特开2004-175830A 2004.06.24

Also Published As

Publication number Publication date
CN1957288A (en) 2007-05-02
CN100465700C (en) 2009-03-04
CN100570435C (en) 2009-12-16
CN1957286A (en) 2007-05-02
CN1961242A (en) 2007-05-09
CN1957287A (en) 2007-05-02
CN100474036C (en) 2009-04-01

Similar Documents

Publication Publication Date Title
EP2038310B1 (en) Actinically crosslinkable copolymers for manufacturing contact lenses
EP2705390B9 (en) Medical devices having homogeneous charge density and methods for making same
US20080003259A1 (en) Modification of surfaces of polymeric articles by Michael addition reaction
CN101312754A (en) Contact lenses with mucin affinity
AU5051799A (en) Method for providing coated moulded polymeric articles
TWI614287B (en) Macroinitiator containing hydrophobic segment
CN1957288B (en) Method for producing protein adsorption-preventing ocular lens material
JP2001323024A (en) Monomer, polymer and ophthalmic lens using the same
JP3715308B1 (en) Ophthalmic lens material and manufacturing method thereof
JP3715310B1 (en) Protein adsorption preventing ophthalmic lens material and method for producing the same
JP3738027B2 (en) Method for producing ophthalmic material for preventing protein adsorption
JP3715309B1 (en) Ophthalmic lens material and manufacturing method thereof
US20080004410A1 (en) Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
US20080003252A1 (en) Functionalized hydrophilic macromonomers and medical devices incorporating same
WO2019083011A1 (en) Medical material surface treatment agent and medical material
JP2002371116A (en) Monomer, polymer, ocular lens and contact lens each using the polymer
ES2366968T3 (en) PROCESS FOR MANUFACTURING MONOMERS OF SILOXANIL CATIÓNIC HYDROPHILES.
KR20210149618A (en) Surface Modification and Application of Silicone Hydrogel Contact Lens
KR20070022027A (en) Eye lens material and manufacturing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120111

Termination date: 20130518